Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) — Form 144: Proposed sale of shares
AI-generated summary
Officer and Director RICHARD PULIK proposed to sell 125,000 shares of Common stock with an aggregate market value of $5,150,575 through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares to be sold were acquired through an exercise of options under a registered plan on November 10, 2026. The filing was submitted on November 10, 2026.
Key facts
- Seller
- RICHARD PULIK
- Relationship
- Officer, Director
- Shares to sell
- 125,000
- Market value
- $5,150,575.00
- Approximate sale date
- Nov 10, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Nov 10, 2026 · Exercise of Options Under a Registered Plan
More ROIV filings
- 144/A
Filed Nov 10, 2026
- 144/A
Filed Nov 10, 2026
- 144/A
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.